Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets

The maintenance of genomic stability is crucial for species survival, and its failure is closely associated with tumorigenesis. The Fanconi anemia (FA) pathway, involving 22 identified genes, plays a central role in repairing DNA interstrand cross-links. Importantly, a germline defect in any of these genes can cause Fanconi’s anemia, a heterogeneous genetic disorder, characterized by congenital growth abnormalities, bone marrow failure, and predisposition to cancer. On the other hand, the breast cancer susceptibility genes, BRCA1 and BRCA2, also known as FANCS and FANCD1, respectively, are involved in the FA pathway; hence, researchers have studied the association between the FA pathway and cancer predisposition. Here, we mainly focused on and systematically reviewed the clinical and mechanistic implications of the predisposition of individuals with abnormalities in the FA pathway to cancer, especially breast cancer.

• Publication year

  2020

• Venue

  Frontiers in Cell and Developmental Biology

• Publication date

  2020-04-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3389/fcell.2020.00160PMID 32300589PMCID 7142266
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BRCA1 Gene

  2020cited by this paper
• PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers

  2019cited by this paper
• Uncoupling of PARP1 Trapping and Inhibition Using Selective PARP1 Degradation

  2019cited by this paper
• XRCC1 protein; Form and function.

  2019cited by this paper
• Fanconi Anemia

  2019cited by this paper
• Hereditary breast cancer; Genetic penetrance and current status with BRCA

  2018cited by this paper
• Homologous recombination and the repair of DNA double-strand breaks

  2018cited by this paper
• Fanconi anemia complementation group C protection against oxidative stress‑induced β‑cell apoptosis.

  2018cited by this paper
• A low‐frequency haplotype spanning SLX4/FANCP constitutes a new risk locus for early‐onset breast cancer (<60 years) and is associated with reduced DNA repair capacity

  2018cited by this paper
• Cancer statistics, 2018

  2018cited by this paper
• CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions

  2018cited by this paper
• Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation

  2018cited by this paper
• PARPs in genome stability and signal transduction: implications for cancer therapy

  2018cited by this paper
• Fanconi Anemia complementation group C protein in metabolic disorders

  2018cited by this paper
• Fanconi anaemia and cancer: an intricate relationship

  2018cited by this paper
• Synthetic lethal therapies for cancer: what’s next after PARP inhibitors?

  2018cited by this paper
• Complexes formed by mutant p53 and their roles in breast cancer

  2018cited by this paper
• PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow

  2018cited by this paper
• Biallelic mutations in the ubiquitin ligase RFWD3 cause Fanconi anemia

  2017cited by this paper
• Current perspectives on CHEK2 mutations in breast cancer

  2017cited by this paper
• Therapeutic targeting and patient selection for cancers with homologous recombination defects

  2017cited by this paper
• University of Groningen Therapeutic targeting and patient selection for cancers with homologous recombination defects

  2017cited by this paper
• Niraparib: First Global Approval

  2017cited by this paper
• The Role of PALB2 in the DNA Damage Response and Cancer Predisposition

  2017cited by this paper
• Compromised BRCA1-PALB2 interaction is associated with breast cancer risk

  2017cited by this paper
• The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk

  2017cited by this paper
• DNA damage response and cancer therapeutics through the lens of the Fanconi Anemia DNA repair pathway

  2017cited by this paper
• Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

  2017cited by this paper
• Synthetic lethality and cancer

  2017cited by this paper
• Association Between Loss-of-Function Mutations Within the FANCM Gene and Early-Onset Familial Breast Cancer

  2017influential reference
• Activation of the FA pathway mediated by phosphorylation and ubiquitination.

  2017cited by this paper
• Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility

  2017cited by this paper
• Family history and risk of breast cancer: an analysis accounting for family structure

  2017cited by this paper
• The Evolution, Functions and Applications of the Breast Cancer Genes BRCA1 and BRCA2.

  2017cited by this paper
• PARP inhibitors: Synthetic lethality in the clinic

  2017cited by this paper
• Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.

  2017cited by this paper
• BRIP1, a potential candidate gene in development of non-BRCA1/2 breast cancer.

  2016cited by this paper
• BRCAness revisited

  2016cited by this paper
• Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children.

  2016cited by this paper
• Analysis of PALB2 mutations in 155 Japanese patients with breast and/or ovarian cancer

  2016cited by this paper
• Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action

  2016cited by this paper
• The role of USP1 autocleavage in DNA interstrand crosslink repair

  2016cited by this paper
• Interplay between Fanconi anemia and homologous recombination pathways in genome integrity

  2016cited by this paper
• FANCD2-associated Nuclease 1, but Not Exonuclease 1 or Flap Endonuclease 1, Is Able to Unhook DNA Interstrand Cross-links in Vitro*

  2015cited by this paper
• FANCA safeguards interphase and mitosis during hematopoiesis in vivo.

  2015cited by this paper
• PALB2 mutations in breast cancer patients from a multi-ethnic region in northwest China

  2015cited by this paper
• Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

  2015cited by this paper
• Mutation analysis of PALB2 gene in French breast cancer families

  2015cited by this paper
• Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.

  2015cited by this paper
• DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.

  2015cited by this paper
• FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor.

  2015cited by this paper
• Fanconi anemia pathway defects in inherited and sporadic cancers.

  2014cited by this paper
• Signalling dynamics in the spindle checkpoint response

  2014influential reference
• Breast-cancer risk in families with mutations in PALB2.

  2014cited by this paper
• BRCA1 and FancJ cooperatively promote interstrand crosslinker induced centrosome amplification through the activation of polo-like kinase 1

  2014cited by this paper
• Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer

  2014cited by this paper
• Breast-cancer risk in families with mutations in PALB2.

  2014cited by this paper
• PALB2: the hub of a network of tumor suppressors involved in DNA damage responses.

  2014cited by this paper
• Analysis of PALB2 Gene in BRCA1/BRCA2 Negative Spanish Hereditary Breast/Ovarian Cancer Families with Pancreatic Cancer Cases

  2013cited by this paper
• p21WAF1 and tumourigenesis: 20 years after

  2013cited by this paper
• Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib

  2013cited by this paper
• Roles of DNA helicases in the mediation and regulation of homologous recombination.

  2013cited by this paper
• Analysis of the Novel Fanconi Anemia Gene SLX4/FANCP in Familial Breast Cancer Cases

  2013cited by this paper
• Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer.

  2013cited by this paper
• Fanconi anemia signaling network regulates the spindle assembly checkpoint.

  2013cited by this paper
• The role of BRCA1 in DNA double-strand repair: past and present.

  2013cited by this paper
• Assessment of SLX4 Mutations in Hereditary Breast Cancers

  2013cited by this paper
• Exome Sequencing Identifies Rare Deleterious Mutations in DNA Repair Genes FANCC and BLM as Potential Breast Cancer Susceptibility Alleles

  2012cited by this paper
• Abstract LB-441: Mutation in SLX4 gen in a multiple case breast cancer family

  2012cited by this paper
• Structural Basis for DNA Damage–Dependent Poly(ADP-ribosyl)ation by Human PARP-1

  2012cited by this paper
• Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors.

  2012cited by this paper
• Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway.

  2012influential reference
• Characterization of BRCA1 Protein Targeting, Dynamics, and Function at the Centrosome

  2012cited by this paper
• The DNA translocase activity of FANCM protects stalled replication forks.

  2012cited by this paper
• Predominance of pathogenic missense variants in the RAD51C gene occurring in breast and ovarian cancer families.

  2012influential reference
• A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2.

  2012cited by this paper
• A Phase I Study of Veliparib in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas

  2012cited by this paper
• SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype

  2011cited by this paper
• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

  2011cited by this paper
• Mutations of the SLX4 gene in Fanconi anemia

  2011cited by this paper
• Involvement of SLX4 in interstrand cross-link repair is regulated by the Fanconi anemia pathway

  2011cited by this paper
• The Fanconi anemia pathway and DNA interstrand cross-link repair

  2011cited by this paper
• BRCA1 and BRCA2: different roles in a common pathway of genome protection

  2011cited by this paper
• RAD51 paralogs: roles in DNA damage signalling, recombinational repair and tumorigenesis.

  2011cited by this paper
• Mutation analysis of the SLX4/FANCP gene in hereditary breast cancer

  2011cited by this paper
• Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2

  2010cited by this paper
• Susceptibility pathways in Fanconi's anemia and breast cancer.

  2010cited by this paper
• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.

  2010cited by this paper
• FANCJ: solving problems in DNA replication.

  2010cited by this paper
• Development of a Functional Assay for Homologous Recombination Status in Primary Cultures of Epithelial Ovarian Tumor and Correlation with Sensitivity to Poly(ADP-Ribose) Polymerase Inhibitors

  2010cited by this paper
• Impact of RING and BRCT Domain Mutations on BRCA1 Protein Stability, Localization and Recruitment to DNA Damage

  2010cited by this paper
• Mutation of the RAD51C gene in a Fanconi anemia–like disorder

  2010cited by this paper
• PARP inhibition: PARP1 and beyond

  2010cited by this paper
• Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

  2010cited by this paper
• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial.

  2010cited by this paper
• A PALB2 mutation associated with high risk of breast cancer

  2010cited by this paper
• PALB2 is an integral component of the BRCA complex required for homologous recombination repair

  2009cited by this paper
• A Mechanism Linking Extra Centrosomes to Chromosomal Instability

  2009cited by this paper
• PALB2 links BRCA1 and BRCA2 in the DNA-damage response.

  2009cited by this paper
• PALB2 Functionally Connects the Breast Cancer Susceptibility Proteins BRCA1 and BRCA2

  2009cited by this paper

• Whole Exome Sequencing Revealed Rare Variants in BRCA2, RAD51D, FANGC, CYP24A1 Genes in Breast/Ovarian Cancer Patients from a Small Buryat Ethnic Group.

  2026cites this paper
• Insights into the host response to ‘dormant’ Mycobacterium tuberculosis utilizing ‘Vitamin C-induced dormant Mtb’ THP-1 cell infection model

  2026influential citation
• Evaluation of predictive biomarkers for late radiation toxicity in breast cancer patients

  2025cites this paper
• Development of translational read-through-inducing drugs as novel therapeutic options for patients with Fanconi anemia

  2025cites this paper
• Pediatric Cancer Genetics and Genomics.

  2025cites this paper
• Prickly pear (Rosa roxburghii Tratt.) extract alleviates ethanol-induced oxidative stress in vivo and in vitro via Fanconi Anemia pathway

  2025cites this paper
• Overview of Roles of Novel Components in the Regulation of DNA Damage Repair in BRCA1-Deficient Cancers: An Update

  2025cites this paper
• The breast tumor immune microenvironment of DNA double-strand break repair pathogenic variant carriers is enriched with tumor-associated macrophages.

  2025cites this paper
• Polyphenols from the husk of T. Acornis suppresses MDA-MB-231 cells growth via Fanconi Anemia pathway.

  2025cites this paper
• Identification of Fanconi anemia pathway genes as novel prognostic biomarkers and therapeutic targets for breast cancer

  2025cites this paper
• Integrative multi-omics reveals common and distinct pathogenic mechanisms and preoperative diagnostic signatures in breast fibroepithelial lesions

  2025cites this paper
• Uncovering the clinical relevance of unclassified variants in DNA repair genes: a focus on BRCA negative Tunisian cancer families

  2024cites this paper
• High- and Moderate-Risk Variants Among Breast Cancer Patients and Healthy Donors Enrolled in Multigene Panel Testing in a Population of Central Russia

  2024cites this paper
• Bioinformatics insights into the role of GFPT1 in breast invasive carcinoma: implications for tumor prognosis, immune modulation, and therapeutic applications

  2024cites this paper
• The coexistence of a BRCA2 germline and a DICER1 somatic variant in two first-degree cousins suggests their potential synergic effect

  2024cites this paper
• A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer

  2024cites this paper
• Germline Predisposition to Hematopoietic Malignancies: An Overview

  2024cites this paper
• Clinical relevance of double heterozygosity revealed by next-generation sequencing of homologous recombination repair pathway genes in South African breast cancer patients

  2024cites this paper
• Hereditary predisposition syndromes to myeloid neoplasms: diseases, genes and mechanisms of development

  2024cites this paper
• Histological and molecular difference in albumen quality between post-adolescent hens and aged hens

  2024cites this paper
• Whole exome sequencing of a novel homozygous missense variant in PALB2 gene leading to Fanconi anaemia complementation group

  2024influential citation
• Use of Neoadjuvant Vandetanib in Aggressive Pediatric Medullary Thyroid Carcinoma.

  2024cites this paper
• Systematic analysis of Mendelian disease-associated gene variants reveals new classes of cancer-predisposing genes

  2023cites this paper
• Chronic hypoxia is associated with transcriptomic reprogramming and increased genomic instability in cancer cells

  2023cites this paper
• ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors

  2023cites this paper
• DNA repair pathways in breast cancer: from mechanisms to clinical applications

  2023cites this paper
• Canonical Wnt and TGF-β/BMP signaling enhance melanocyte regeneration but suppress invasiveness, migration, and proliferation of melanoma cells

  2023cites this paper
• Integrating somatic CNV and gene expression in breast cancers from women with PTEN hamartoma tumor syndrome

  2023cites this paper
• XMR: an explainable multimodal neural network for drug response prediction

  2023cites this paper
• A comprehensive analysis of Fanconi anemia genes in Chinese patients with high-risk hereditary breast cancer

  2023cites this paper
• Research progress of the Fanconi anemia pathway and premature ovarian insufficiency

  2023cites this paper
• Investigation of (Epi)genetic causes in syndromic short children born small for gestational age.

  2023cites this paper
• The Tumor Suppressor BRCA1/2, Cancer Susceptibility and Genome Instability in Gynecological and Mammary Cancers

  2023cites this paper
• Targeting the DNA Damage Response for Cancer Therapy

  2023cites this paper
• Applications of advanced technologies for detecting genomic structural variation.

  2023cites this paper
• Down-regulation of FA-BRCA Pathway in Cervical Carcinoma Gradually Reversed During the Development of Chemo-tolerance: Clinical Implications

  2023cites this paper
• Exploring the hub genes and potential drugs involved in Fanconi anemia using microarray datasets and bioinformatics analysis

  2023cites this paper
• Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and Therapy

  2022cites this paper
• Cancer and Radiosensitivity Syndromes: Is Impaired Nuclear ATM Kinase Activity the Primum Movens?

  2022cites this paper
• Chromatin Ubiquitination Guides DNA Double Strand Break Signaling and Repair

  2022cites this paper
• Newborn Screening by Genomic Sequencing: Opportunities and Challenges

  2022cites this paper
• Exome sequencing reveals a distinct somatic genomic landscape in breast cancer from women with germline PTEN variants.

  2022cites this paper
• Familial history and prevalence of BRCA1, BRCA2 and TP53 pathogenic variants in HBOC Brazilian patients from a public healthcare service

  2022cites this paper
• Characterization of somatic mutations and pathway alterations during hepatocellular carcinoma vascular invasion using next-generation sequencing

  2022cites this paper
• Structure and Function of SNM1 Family Nucleases.

  2022cites this paper
• HIV-1 exploits the Fanconi anemia pathway for viral DNA integration

  2022cites this paper
• Conserved function of Drosophila Fancd2 monoubiquitination in response to double-strand DNA breaks

  2022cites this paper
• Genetics and genomics of bone marrow failure syndrome

  2022cites this paper
• Evaluation of conformational transitions of h-BRCA2 functional domain and unclassified variant Arg2502Cys using multimodal approach.

  2022cites this paper
• A novel group of genes that cause endocrine resistance in breast cancer identified by dynamic gene expression analysis

  2022cites this paper
• Therapeutic benefits of niraparib tosylate as radio sensitizer in esophageal squamous cell carcinoma: an in vivo and in vitro preclinical study

  2022cites this paper
• Wnt and BMP signaling enhance melanocyte regeneration and suppress melanoma cell migration

  2022cites this paper
• Identifying Cancer Patient Subgroups by Finding Co-Modules From the Driver Mutation Profiles and Downstream Gene Expression Profiles

  2021cites this paper
• ASPM promotes homologous recombination-mediated DNA repair by safeguarding BRCA1 stability

  2021cites this paper
• Feasibility of breast radiation therapy in a Fanconi Anemia patient diagnosed with breast cancer: A case report and review of literature

  2021cites this paper
• The overexpression of DNA repair genes in invasive ductal and lobular breast carcinomas: Insights on individual variations and precision medicine

  2021cites this paper
• Homologous Recombination Deficiencies and Hereditary Tumors

  2021cites this paper
• The Fanconi anemia pathway and Breast Cancer: A comprehensive review of clinical data.

  2021cites this paper
• DNA damage responses that enhance resilience to replication stress

  2021cites this paper
• Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.

  2021cites this paper
• Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing

  2021cites this paper
• Genomic Instability and Cancer Risk Associated with Erroneous DNA Repair

  2021cites this paper
• A Novel Group of Genes that Causes Endocrine Resistance in Breast Cancer Identified by Dynamic Gene Expression Analysis

  2021cites this paper
• Identification of Prognostic Factors Related to Super Enhancer-Regulated ceRNA Network in Metastatic Lung Adenocarcinoma

  2021cites this paper
• DNA double-strand break end resection: a critical relay point for determining the pathway of repair and signaling

  2020cites this paper
• The emerging role of miRNA clusters in breast cancer progression.

  2020cites this paper
• Targeting DNA Damage and Repair (DDR) Pathways: Advances in Understanding and Therapeutic Implications

  year unknowncites this paper
• Overview of the Main Signalling Pathways and Genetic Predispositions Involved in Breast Carcinogenesis By

  year unknowncites this paper